Increased Expression of SHMT2 Is Associated With Poor Prognosis and Advanced Pathological Grade in Oral Squamous Cell Carcinoma
This study focused on the expression of mitochondrial serine hydroxymethyltransferase (SHMT2) in oral squamous cell carcinoma (OSCC) and its correlation with clinical traits and the prognosis of OSCC patients. Immunochemical staining and Western blotting were used to quantify the expression of SHMT2...
Main Authors: | Zhi-Zhong Wu, Shuo Wang, Qi-Chao Yang, Xiao-Long Wang, Lei-Lei Yang, Bing Liu, Zhi-Jun Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.588530/full |
Similar Items
-
Overexpression of SHMT2 Predicts a Poor Prognosis and Promotes Tumor Cell Growth in Bladder Cancer
by: Peng Zhang, et al.
Published: (2021-06-01) -
SHMT2 expression as a diagnostic and prognostic marker for thyroid cancer
by: Meihua Jin, et al.
Published: (2021-06-01) -
Evaluating the clinical significance of SHMT2 and its co-expressed gene in human kidney cancer
by: Huan Wang, et al.
Published: (2020-10-01) -
Influence of Immune Microenvironment on Diagnosis and Prognosis of Head and Neck Squamous Cell Carcinoma
by: Guohong Liu, et al.
Published: (2021-03-01) -
Silencing SHMT2 inhibits the progression of tongue squamous cell carcinoma through cell cycle regulation
by: Yan Liao, et al.
Published: (2021-04-01)